ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-32P12868
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2023
BUY CHAPTERS

Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2024

Code: QYRE-Auto-32P12868
Report
July 2024
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Livongo
EnteroMedics
SHANGYI

Digital Therapeutics for Endocrine System Diseases Market

Digital Therapeutics for Endocrine System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent endocrine system diseases.
The global Digital Therapeutics for Endocrine System Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Digital Therapeutics for Endocrine System Diseases in Diabetes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Digital Therapeutics for Endocrine System Diseases include Livongo, SHANGYI and EnteroMedics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Endocrine System Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Endocrine System Diseases.

Report Scope

The Digital Therapeutics for Endocrine System Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Therapeutics for Endocrine System Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Therapeutics for Endocrine System Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Digital Therapeutics for Endocrine System Diseases Market Report

Report Metric Details
Report Name Digital Therapeutics for Endocrine System Diseases Market
Segment by Type
  • Prevention
  • Management
  • Treatment
Segment by Application
  • Diabetes
  • Metabolic Syndrome
  • Obesity
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Livongo, SHANGYI, EnteroMedics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Digital Therapeutics for Endocrine System Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The main players in the Digital Therapeutics for Endocrine System Diseases Market are Livongo, SHANGYI, EnteroMedics

What are the Application segmentation covered in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The Applications covered in the Digital Therapeutics for Endocrine System Diseases Market report are Diabetes, Metabolic Syndrome, Obesity, Other

What are the Type segmentation covered in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The Types covered in the Digital Therapeutics for Endocrine System Diseases Market report are Prevention, Management, Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prevention
1.2.3 Management
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Digital Therapeutics for Endocrine System Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Metabolic Syndrome
1.3.4 Obesity
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics for Endocrine System Diseases Market Perspective (2019-2030)
2.2 Digital Therapeutics for Endocrine System Diseases Growth Trends by Region
2.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital Therapeutics for Endocrine System Diseases Historic Market Size by Region (2019-2024)
2.2.3 Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2025-2030)
2.3 Digital Therapeutics for Endocrine System Diseases Market Dynamics
2.3.1 Digital Therapeutics for Endocrine System Diseases Industry Trends
2.3.2 Digital Therapeutics for Endocrine System Diseases Market Drivers
2.3.3 Digital Therapeutics for Endocrine System Diseases Market Challenges
2.3.4 Digital Therapeutics for Endocrine System Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue
3.1.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue (2019-2024)
3.1.2 Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Players (2019-2024)
3.2 Global Digital Therapeutics for Endocrine System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Therapeutics for Endocrine System Diseases Revenue
3.4 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio
3.4.1 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Endocrine System Diseases Revenue in 2023
3.5 Digital Therapeutics for Endocrine System Diseases Key Players Head office and Area Served
3.6 Key Players Digital Therapeutics for Endocrine System Diseases Product Solution and Service
3.7 Date of Enter into Digital Therapeutics for Endocrine System Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics for Endocrine System Diseases Breakdown Data by Type
4.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Type (2019-2024)
4.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2025-2030)
5 Digital Therapeutics for Endocrine System Diseases Breakdown Data by Application
5.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Application (2019-2024)
5.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Digital Therapeutics for Endocrine System Diseases Market Size (2019-2030)
6.2 North America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024)
6.4 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Therapeutics for Endocrine System Diseases Market Size (2019-2030)
7.2 Europe Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024)
7.4 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size (2019-2030)
8.2 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Therapeutics for Endocrine System Diseases Market Size (2019-2030)
9.2 Latin America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024)
9.4 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size (2019-2030)
10.2 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Livongo
11.1.1 Livongo Company Detail
11.1.2 Livongo Business Overview
11.1.3 Livongo Digital Therapeutics for Endocrine System Diseases Introduction
11.1.4 Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
11.1.5 Livongo Recent Development
11.2 SHANGYI
11.2.1 SHANGYI Company Detail
11.2.2 SHANGYI Business Overview
11.2.3 SHANGYI Digital Therapeutics for Endocrine System Diseases Introduction
11.2.4 SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
11.2.5 SHANGYI Recent Development
11.3 EnteroMedics
11.3.1 EnteroMedics Company Detail
11.3.2 EnteroMedics Business Overview
11.3.3 EnteroMedics Digital Therapeutics for Endocrine System Diseases Introduction
11.3.4 EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
11.3.5 EnteroMedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Livongo
EnteroMedics
SHANGYI
List of Tables
    Table 1. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Prevention
    Table 3. Key Players of Management
    Table 4. Key Players of Treatment
    Table 5. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2019-2024)
    Table 9. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2025-2030)
    Table 11. Digital Therapeutics for Endocrine System Diseases Market Trends
    Table 12. Digital Therapeutics for Endocrine System Diseases Market Drivers
    Table 13. Digital Therapeutics for Endocrine System Diseases Market Challenges
    Table 14. Digital Therapeutics for Endocrine System Diseases Market Restraints
    Table 15. Global Digital Therapeutics for Endocrine System Diseases Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players (2019-2024)
    Table 17. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2023)
    Table 18. Ranking of Global Top Digital Therapeutics for Endocrine System Diseases Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Digital Therapeutics for Endocrine System Diseases Product Solution and Service
    Table 22. Date of Enter into Digital Therapeutics for Endocrine System Diseases Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Digital Therapeutics for Endocrine System Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2019-2024)
    Table 26. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2025-2030)
    Table 28. Global Digital Therapeutics for Endocrine System Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2019-2024)
    Table 30. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2025-2030)
    Table 32. North America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Livongo Company Detail
    Table 48. Livongo Business Overview
    Table 49. Livongo Digital Therapeutics for Endocrine System Diseases Product
    Table 50. Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024) & (US$ Million)
    Table 51. Livongo Recent Development
    Table 52. SHANGYI Company Detail
    Table 53. SHANGYI Business Overview
    Table 54. SHANGYI Digital Therapeutics for Endocrine System Diseases Product
    Table 55. SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024) & (US$ Million)
    Table 56. SHANGYI Recent Development
    Table 57. EnteroMedics Company Detail
    Table 58. EnteroMedics Business Overview
    Table 59. EnteroMedics Digital Therapeutics for Endocrine System Diseases Product
    Table 60. EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2019-2024) & (US$ Million)
    Table 61. EnteroMedics Recent Development
    Table 62. Research Programs/Design for This Report
    Table 63. Key Data Information from Secondary Sources
    Table 64. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Digital Therapeutics for Endocrine System Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Digital Therapeutics for Endocrine System Diseases Market Share by Type: 2023 VS 2030
    Figure 3. Prevention Features
    Figure 4. Management Features
    Figure 5. Treatment Features
    Figure 6. Global Digital Therapeutics for Endocrine System Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Digital Therapeutics for Endocrine System Diseases Market Share by Application: 2023 VS 2030
    Figure 8. Diabetes Case Studies
    Figure 9. Metabolic Syndrome Case Studies
    Figure 10. Obesity Case Studies
    Figure 11. Other Case Studies
    Figure 12. Digital Therapeutics for Endocrine System Diseases Report Years Considered
    Figure 13. Global Digital Therapeutics for Endocrine System Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Digital Therapeutics for Endocrine System Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region: 2023 VS 2030
    Figure 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players in 2023
    Figure 17. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue in 2023
    Figure 19. North America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2019-2030)
    Figure 21. United States Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Digital Therapeutics for Endocrine System Diseases Market Share by Country (2019-2030)
    Figure 25. Germany Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Share by Region (2019-2030)
    Figure 33. China Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2019-2030)
    Figure 41. Mexico Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Share by Country (2019-2030)
    Figure 45. Turkey Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Livongo Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
    Figure 48. SHANGYI Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
    Figure 49. EnteroMedics Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2019-2024)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Oral Blood Glucose Regulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19K14366
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Hyperthyroidism Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-10V14301
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Dipeptidyl Peptidase-4 Inhibitors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-24J13911
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Oral Hypoglycemic Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32J13966
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions